Archived Facts

Posts Tagged ‘drug-intended’

Canadian drugmaker Biovail Corp. said Thursday it posted a loss in the first quarter because of costs involved with licensing a treatment for schizophrenia symptoms and a drug intended to treat a breathing disorder.

See the article here:
Biovail takes 1Q loss on drug acquisition costs

Related Posts: